Mom Jessica and the Tumor Medicine, but the Haters Attack Her. Sister: "He Raised His Voice to Make Himself Heard and Did It Not only for herself."
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.5 Articles
5 Articles
This tumor does not give so much time, unfortunately, and we must fight to try to live a little more. With these words Jessica Scarpa, 36 years old, for 2 years of metastatic pancreatic cancer, is addressed to anyone who listens to it in a new video published on the channels of Change.org Italia. His [...]
"This tumor does not give so much time, unfortunately, and we must fight to try to live a little 'more." With these words Jessica Scarpa, 36 years old, for 2 years sick of cancer to the metastatic pancreas, turns to anyone who listens to it in a new video published on the channels of Change.org Italy. His invitation is only one: "Sign the petition that asks to make the Daraxonrasib accessible throughout Italy." The petition, over 42 thousand sig…
This tumor does not give so much time, unfortunately, and we have to fight to try to live a little more. With these words Jessica Scarpa, 36 years old, for 2 years sick of metastatic pancreatic cancer, is addressed to anyone who listens to it in a new video published on the channels of Change.org Italy. Her [...] L'articolo L'appello sui social di Jessica Scarpa: Daraxonrasib per tutti i patienti, firmate la petitione di Emanuela Scarpa proviene…
Jessica Scarpa has obtained Daraxonrasib thanks to the intervention of the Lombardy Region, but her battle continues: "That drug serves all the people who have the tumor that I have." Read more Jessica Scarpa started the cure, fundraising record: "I would like to make a...
The 36-year-old Olginate has been attacked online after the decision of the Region to finance the Daxonrasib. The fundraising has been suspended and the money will be donated to the researchers of the Airc and to the Oncology of the hospital of Lecco
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
